Back to BARCLAYS PLC BARCLAYS PLC

NAUTNAUT
Showing 8 of 18 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in NAUTILUS BIOTECHNOLOGY INC

Yes. Barclays holds 725,321 shares of NAUT (Nautilus Biotechnology), worth $1.4M, as of its Q2 2026 13F filing. It increased the position from 73,325 shares in Q1 2026. Barclays has held NAUT since Q1 2022, across 18 quarterly 13F filings.

Current Value

$1.4M

Current Shares

725,321

Total Value Change

+$1.1M

Total Shares Change

+619,147

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
725,321
+889.2%
$1.4M0.0%$1.87
41
2026-Q1
Increased
73,325
+52.0%
$284,5010.0%$3.88
33
2025-Q4
Unchanged
48,254
0.0%
$94,0950.0%$1.95
0
2025-Q3
Decreased
48,254
-16.9%
$40,7700.0%$0.85
0
2025-Q2
Decreased
58,089
-42.5%
$42,1080.0%$0.73
0
2025-Q1
Decreased
100,967
-19.4%
$86,9330.0%$0.86
0
2024-Q4
Increased
125,204
+17.9%
$210,3430.0%$1.68
27
2024-Q3
Increased
106,174
+79.6%
$302,5960.0%$2.85
36

Other major holders of NAUT: RA CAPITAL MANAGEMENT, L.P., Alyeska Investment Group, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used